113 related articles for article (PubMed ID: 21670065)
1. A substrate-based approach to convert SerpinB1 into a specific inhibitor of proteinase 3, the Wegener's granulomatosis autoantigen.
Jégot G; Derache C; Castella S; Lahouassa H; Pitois E; Jourdan ML; Remold-O'Donnell E; Kellenberger C; Gauthier F; Korkmaz B
FASEB J; 2011 Sep; 25(9):3019-31. PubMed ID: 21670065
[TBL] [Abstract][Full Text] [Related]
2. Mapping of conformational epitopes on human proteinase 3, the autoantigen of Wegener's granulomatosis.
Kuhl A; Korkmaz B; Utecht B; Kniepert A; Schönermarck U; Specks U; Jenne DE
J Immunol; 2010 Jul; 185(1):387-99. PubMed ID: 20530264
[TBL] [Abstract][Full Text] [Related]
3. The crystal structure of PR3, a neutrophil serine proteinase antigen of Wegener's granulomatosis antibodies.
Fujinaga M; Chernaia MM; Halenbeck R; Koths K; James MN
J Mol Biol; 1996 Aug; 261(2):267-78. PubMed ID: 8757293
[TBL] [Abstract][Full Text] [Related]
4. 'Classic' anti-neutrophil cytoplasmic autoantibodies (cANCA), 'Wegener's autoantigen' and their immunopathogenic role in Wegener's granulomatosis.
Gross WL; Csernok E; Flesch BK
J Autoimmun; 1993 Apr; 6(2):171-84. PubMed ID: 8388690
[TBL] [Abstract][Full Text] [Related]
5. Proteinase 3, Wegener's autoantigen: from gene to antigen.
van der Geld YM; Limburg PC; Kallenberg CG
J Leukoc Biol; 2001 Feb; 69(2):177-90. PubMed ID: 11272267
[TBL] [Abstract][Full Text] [Related]
6. Antineutrophil cytoplasmic autoantibodies in Wegener's granulomatosis recognize conformational epitope(s) on proteinase 3.
Bini P; Gabay JE; Teitel A; Melchior M; Zhou JL; Elkon KB
J Immunol; 1992 Aug; 149(4):1409-15. PubMed ID: 1380042
[TBL] [Abstract][Full Text] [Related]
7. Proteinase 3, the autoantigen in granulomatosis with polyangiitis, associates with calreticulin on apoptotic neutrophils, impairs macrophage phagocytosis, and promotes inflammation.
Gabillet J; Millet A; Pederzoli-Ribeil M; Tacnet-Delorme P; Guillevin L; Mouthon L; Frachet P; Witko-Sarsat V
J Immunol; 2012 Sep; 189(5):2574-83. PubMed ID: 22844112
[TBL] [Abstract][Full Text] [Related]
8. Epitopes on proteinase-3 recognized by antibodies from patients with Wegener's granulomatosis.
Williams RC; Staud R; Malone CC; Payabyab J; Byres L; Underwood D
J Immunol; 1994 May; 152(9):4722-37. PubMed ID: 8157982
[TBL] [Abstract][Full Text] [Related]
9. Relevance of the mouse model as a therapeutic approach for neutrophil proteinase 3-associated human diseases.
Korkmaz B; Jenne DE; Gauthier F
Int Immunopharmacol; 2013 Dec; 17(4):1198-205. PubMed ID: 23886601
[TBL] [Abstract][Full Text] [Related]
10. Design and use of highly specific substrates of neutrophil elastase and proteinase 3.
Korkmaz B; Attucci S; Moreau T; Godat E; Juliano L; Gauthier F
Am J Respir Cell Mol Biol; 2004 Jun; 30(6):801-7. PubMed ID: 14693667
[TBL] [Abstract][Full Text] [Related]
11. A selective reversible azapeptide inhibitor of human neutrophil proteinase 3 derived from a high affinity FRET substrate.
Epinette C; Croix C; Jaquillard L; Marchand-Adam S; Kellenberger C; Lalmanach G; Cadene M; Viaud-Massuard MC; Gauthier F; Korkmaz B
Biochem Pharmacol; 2012 Mar; 83(6):788-96. PubMed ID: 22209715
[TBL] [Abstract][Full Text] [Related]
12. Computational prediction of the binding site of proteinase 3 to the plasma membrane.
Hajjar E; Mihajlovic M; Witko-Sarsat V; Lazaridis T; Reuter N
Proteins; 2008 Jun; 71(4):1655-69. PubMed ID: 18076025
[TBL] [Abstract][Full Text] [Related]
13. Interaction of proteinase 3 with its associated partners: implications in the pathogenesis of Wegener's granulomatosis.
Witko-Sarsat V; Reuter N; Mouthon L
Curr Opin Rheumatol; 2010 Jan; 22(1):1-7. PubMed ID: 19881350
[TBL] [Abstract][Full Text] [Related]
14. Membrane-bound proteinase 3 and its receptors: relevance for the pathogenesis of Wegener's Granulomatosis.
Hu N; Westra J; Kallenberg CG
Autoimmun Rev; 2009 May; 8(6):510-4. PubMed ID: 19185066
[TBL] [Abstract][Full Text] [Related]
15. Expression of the human autoantigen of Wegener's granulomatosis (PR3) in a baculovirus expression system.
Szymkowiak CH; Johnston TW; Csernok E; Gross WL
Biochem Biophys Res Commun; 1996 Feb; 219(2):283-9. PubMed ID: 8604978
[TBL] [Abstract][Full Text] [Related]
16. Constitutive membrane expression of proteinase 3 (PR3) and neutrophil activation by anti-PR3 antibodies.
van Rossum AP; Rarok AA; Huitema MG; Fassina G; Limburg PC; Kallenberg CG
J Leukoc Biol; 2004 Dec; 76(6):1162-70. PubMed ID: 15331626
[TBL] [Abstract][Full Text] [Related]
17. Activation, apoptosis, and clearance of neutrophils in Wegener's granulomatosis.
van Rossum AP; Limburg PC; Kallenberg CG
Ann N Y Acad Sci; 2005 Jun; 1051():1-11. PubMed ID: 16126939
[TBL] [Abstract][Full Text] [Related]
18. Inhibitors and Antibody Fragments as Potential Anti-Inflammatory Therapeutics Targeting Neutrophil Proteinase 3 in Human Disease.
Korkmaz B; Lesner A; Guarino C; Wysocka M; Kellenberger C; Watier H; Specks U; Gauthier F; Jenne DE
Pharmacol Rev; 2016 Jul; 68(3):603-30. PubMed ID: 27329045
[TBL] [Abstract][Full Text] [Related]
19. Apoptosis-induced proteinase 3 membrane expression is independent from degranulation.
Durant S; Pederzoli M; Lepelletier Y; Canteloup S; Nusbaum P; Lesavre P; Witko-Sarsat V
J Leukoc Biol; 2004 Jan; 75(1):87-98. PubMed ID: 14525959
[TBL] [Abstract][Full Text] [Related]
20. New selective peptidyl di(chlorophenyl) phosphonate esters for visualizing and blocking neutrophil proteinase 3 in human diseases.
Guarino C; Legowska M; Epinette C; Kellenberger C; Dallet-Choisy S; Sieńczyk M; Gabant G; Cadene M; Zoidakis J; Vlahou A; Wysocka M; Marchand-Adam S; Jenne DE; Lesner A; Gauthier F; Korkmaz B
J Biol Chem; 2014 Nov; 289(46):31777-31791. PubMed ID: 25288799
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
